Sun Pharma has become the first manufacturer after Novo Nordisk to secure a South African semaglutide approval, intensifying competition as rivals including Aspen, Natco and Lupin prepare their own market entries.
Sun Pharma has become the first manufacturer after Novo Nordisk to secure a South African semaglutide approval, intensifying competition as rivals including Aspen, Natco and Lupin prepare their own market entries.